TY  - JOUR
AU  - Bhatla, Neerja
AU  - Muwonge, Richard
AU  - Malvi, Sylla G
AU  - Joshi, Smita
AU  - Poli, Usha Rani Reddy
AU  - Lucas, Eric
AU  - Esmy, Pulikkottil O
AU  - Verma, Yogesh
AU  - Shah, Anand
AU  - Zomawia, Eric
AU  - Pimple, Sharmila
AU  - Jayant, Kasturi
AU  - Hingmire, Sanjay
AU  - Chiwate, Aruna
AU  - Vashist, Shachi
AU  - Mishra, Gauravi
AU  - Jadhav, Radhika
AU  - Siddiqi, Maqsood
AU  - Anantharaman, Devasena
AU  - Panicker, Gitika
AU  - Butt, Julia
AU  - Sankaran, Subha
AU  - Kannan, Thiraviam Pillai Rameshwari Ammal
AU  - Varghese, Rintu
AU  - Kartha, Purnima
AU  - Pillai, M Radhakrishna
AU  - Waterboer, Tim
AU  - Müller, Martin
AU  - Sehr, Peter
AU  - Unger, Elizabeth R
AU  - Sankaranarayanan, Rengaswamy
AU  - Basu, Partha
TI  - Impact of age at vaccination and cervical HPV infection status on binding and neutralizing antibody titers at 10 years after receiving single or higher doses of quadrivalent HPV vaccine.
JO  - Human vaccines & immunotherapeutics
VL  - 19
IS  - 3
SN  - 2164-5515
CY  - Austin, Tex.
PB  - Landes Bioscience
M1  - DKFZ-2023-02679
SP  - 2289242
PY  - 2023
AB  - Long-term follow-up of a cohort of unmarried girls who received one, two, or three doses of quadrivalent HPV vaccine, between 10 and 18 years of age, in an Indian multi-centric study allowed us to compare antibody responses between the younger and older age cohorts at 10-years post-vaccination, and study the impact of initiation of sexual activity and cervical HPV infections on antibody levels. Among the younger (10-14 years) recipients of a single dose, 97.7
KW  - HPV (Other)
KW  - Human papillomavirus (Other)
KW  - age-stratified (Other)
KW  - binding antibody (Other)
KW  - neutralizing antibody (Other)
KW  - single dose (Other)
KW  - vaccine (Other)
LB  - PUB:(DE-HGF)16
C6  - pmid:38078840
DO  - DOI:10.1080/21645515.2023.2289242
UR  - https://inrepo02.dkfz.de/record/286103
ER  -